A. Heroux

423 total citations
16 papers, 250 citations indexed

About

A. Heroux is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Biomedical Engineering. According to data from OpenAlex, A. Heroux has authored 16 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Biomedical Engineering. Recurrent topics in A. Heroux's work include Transplantation: Methods and Outcomes (13 papers), Mechanical Circulatory Support Devices (5 papers) and Viral Infections and Immunology Research (4 papers). A. Heroux is often cited by papers focused on Transplantation: Methods and Outcomes (13 papers), Mechanical Circulatory Support Devices (5 papers) and Viral Infections and Immunology Research (4 papers). A. Heroux collaborates with scholars based in United States and Australia. A. Heroux's co-authors include Salpy V. Pamboukian, Anat R. Tambur, Stephanie H. Dunlap, Maria Rosa Costanzo, Peter Meyer, Mary McLeod, Linda Bartlett, M. Obadah Al Chekakie, Hassan Nemeh and Walter Jeske and has published in prestigious journals such as Transplantation, The Journal of Heart and Lung Transplantation and Journal of Cardiac Failure.

In The Last Decade

A. Heroux

15 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Heroux United States	7	191	125	74	73	23	16	250
A. Aliabadi-Zuckermann Austria	9	179 0.9×	84 0.7×	67 0.9×	54 0.7×	29 1.3×	32	226
José María Arizón del Prado Spain	11	344 1.8×	176 1.4×	161 2.2×	141 1.9×	53 2.3×	40	454
C. Cornu-Artis Switzerland	5	209 1.1×	248 2.0×	29 0.4×	41 0.6×	51 2.2×	9	319
Erwin de Vries Netherlands	13	357 1.9×	173 1.4×	42 0.6×	139 1.9×	38 1.7×	17	415
Jennie H. Kwon United States	10	242 1.3×	64 0.5×	44 0.6×	114 1.6×	33 1.4×	41	284
Marian Vanek United States	7	252 1.3×	193 1.5×	43 0.6×	37 0.5×	58 2.5×	12	386
Dor Yoeli United States	9	160 0.8×	57 0.5×	13 0.2×	20 0.3×	70 3.0×	19	258
Jenna Scheffert United States	7	149 0.8×	101 0.8×	10 0.1×	16 0.2×	72 3.1×	12	279
Pablo García Pavía Spain	5	143 0.7×	29 0.2×	33 0.4×	110 1.5×	11 0.5×	8	219
Antonio Coppolino United States	7	161 0.8×	145 1.2×	21 0.3×	43 0.6×	57 2.5×	21	291

Countries citing papers authored by A. Heroux

Since Specialization

Citations

This map shows the geographic impact of A. Heroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Heroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Heroux more than expected).

Fields of papers citing papers by A. Heroux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Heroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Heroux. The network helps show where A. Heroux may publish in the future.

Co-authorship network of co-authors of A. Heroux

This figure shows the co-authorship network connecting the top 25 collaborators of A. Heroux. A scholar is included among the top collaborators of A. Heroux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Heroux. A. Heroux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Walenga, Jeanine M., et al.. (2015). Cellular Microparticles as Predictive Markers for Adverse Events in Patients With Implanted Ventricular Assist Devices. The Journal of Heart and Lung Transplantation. 34(4). S201–S202. 1 indexed citations

Bailey, Joseph I., et al.. (2014). Etiology and Timing of Readmissions After LVAD Implantation. Journal of Cardiac Failure. 20(8). S86–S86. 1 indexed citations

Heroux, A. & Salpy V. Pamboukian. (2013). Neurologic aspects of heart transplantation. Handbook of clinical neurology. 121. 1229–1236. 17 indexed citations

Walenga, Jeanine M., et al.. (2012). Left Ventricular Assist Device–Induced Coagulation and Platelet Activation and Effect of the Current Anticoagulant Therapy Regimen. Clinical and Applied Thrombosis/Hemostasis. 19(3). 249–255. 11 indexed citations

Chekakie, M. Obadah Al, et al.. (2009). Gemella Morbillorum Prosthetic Valve Endocarditis. Congestive Heart Failure. 15(6). 291–292. 12 indexed citations

White‐Williams, Connie, Kathleen L. Grady, David C. Naftel, et al.. (2009). 178: The Relationship of Social Support and Quality of Life 5 to 10 Years after Heart Transplantation. The Journal of Heart and Lung Transplantation. 28(2). S128–S128. 2 indexed citations

Heroux, A., et al.. (2009). Left Ventricular Torsion Is Reduced in Heart Transplant Patients. Journal of Cardiac Failure. 15(6). S53–S53. 1 indexed citations

Higgins, Rana M., A. Heroux, Bruce Rybarczyk, et al.. (2008). 151: Symptom Frequency and Distress from 5 to 10 Years after Heart Transplantation. The Journal of Heart and Lung Transplantation. 27(2). S114–S114. 1 indexed citations

Feldman, Charles L., et al.. (2007). 340: Sudden cardiac death in heart transplant patients: Is there a role for defibrillators?. The Journal of Heart and Lung Transplantation. 26(2). S182–S182. 6 indexed citations

10.

Tambur, Anat R., Salpy V. Pamboukian, Maria Rosa Costanzo, & A. Heroux. (2006). Genetic Polymorphism in Platelet-derived Growth Factor and Vascular Endothelial Growth Factor Are Significantly Associated With Cardiac Allograft Vasculopathy. The Journal of Heart and Lung Transplantation. 25(6). 690–698. 31 indexed citations

11.

Tambur, Anat R., et al.. (2005). The Presence of HLA-Directed Antibodies after Heart Transplantation Is Associated with Poor Allograft Outcome. Transplantation. 80(8). 1019–1025. 124 indexed citations

12.

Bellg, Albert J., David C. Naftel, Bruce Rybarczyk, et al.. (2003). Patient adherence at 5 to 6 years after heart transplantation. The Journal of Heart and Lung Transplantation. 22(1). S127–S127. 1 indexed citations

13.

Naftel, David C., Connie White‐Williams, Janice Ryan Young, et al.. (2003). Predictors of quality of life at 5 to 6 years after heart transplantation. The Journal of Heart and Lung Transplantation. 22(1). S220–S220.

14.

Pamboukian, Salpy V., Maria Rosa Costanzo, Peter Meyer, et al.. (2003). Influence of race in heart failure and cardiac transplantation: Mortality differences are eliminated by specialized, comprehensive care. Journal of Cardiac Failure. 9(2). 80–86. 34 indexed citations

15.

Boehmer, John, Robert N. Brown, C V Leier, et al.. (2002). Advanced allograft coronary artery disease: interaction between pre and post-transplant risk factors from a 10-year multi-institutional study. The Journal of Heart and Lung Transplantation. 21(1). 56–56. 3 indexed citations

16.

Tambur, Anat R., et al.. (2001). Flow panel reactive antibody monitoring following heart transplantation. Transplantation Proceedings. 33(7-8). 3295–3297. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact